Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • World
  • A GREAT MANUFACTURING INNOVATION BY OXGENE

New insulin treatment for Type 2 diabetes? Find out.

DNA Methylation Role in Ageing Human Muscles

A GREAT MANUFACTURING  INNOVATION BY OXGENE
  • World

A GREAT MANUFACTURING INNOVATION BY OXGENE

bioxone September 24, 2020September 24, 2020

Subhangi Das, Bankura Sammilani College

OXGENE has developed scalable gene therapy technology, marking the day as the launch of its scalable, plasmid-free technical system for AAV. OXGENE ‘s new TESSA technology is a great illustration of the change in AAV manufacturing.

 Adeno associated virus or AAV having benefits such as low immunogenicity and a favorable safety profile is used to deliver gene therapies to a patient.

Manufacturing systems have not kept up with advances in technology, leaving these therapies subject to inherent batch-to-batch variability, costly, and difficult to produce at scale.

This new technology is expected to transform the way AAV is manufactured. OXGENE has many developing features that validated TESSA vectors for AAV2,5,6 and 9 to suffice demands for industrial works, large projects.

This invention may be a boon to the biotechnological field, removing the reliance on expensive and limiting plasmids for AAV manufacture.

Source: https://www.oxgene.com/

Visit https://bioxone.in// for more updates.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged AAV Immunogenicity OXGENE oxgene news TESSA therapeutics US Vectors

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • World

DNA Methylation Role in Ageing Human Muscles

bioxone September 25, 2020

-Thota Kanishka Rao, Amity University Kolkata Skeletal muscle is one of the three major muscle types, composed of skeletal muscle tissue which is under the voluntary control of the somatic system. Maintaining muscle mass and performance into older age is prime for human health-span and quality of life. Five to ten per cent of older […]

DNA Methylation

Related Post

  • BiotechToday
  • World

OAS1 p46 Sensor locating the hidden place of RNA viruses

bioxone August 19, 2021August 19, 2021

Husna, Amity University Kolkata How can RNA viruses be detected in a cell? Some species of RNA viruses have the ability to cover themselves, hide inside a cell, and create copies of themselves. Positive-strand RNA viruses like the SARS-CoV-2 virus, flaviviruses (West Nile and Zika), as well as picornaviruses (cause polio and some heart and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ProteinGAN: The merge of machine learning and proteomics

bioxone April 12, 2021April 12, 2021

Camelia Bhattacharyya, Amity University Kolkata Proteins are the main functional biomolecules in the human body. These are the ones that are responsible for most of the functions in our body and maintains the structure and regulates other metabolic balances in the body. Thus, proper knowledge of it is a must. But the highly complicated structure […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Transcriptomic analysis of etiology behind fatality in HIV patients

BioTech Today June 22, 2021June 21, 2021

Kanikah Mehndiratta Transcriptomic analysis has been a recent approach to identify biomarkers associated with normal or diseased physiology in patients. An obvious approach to targeting any infection or disease through treatment strategies or prophylaxis requires a proper understanding of the mechanisms of its pathogenesis. Researching on better and more effective treatment approaches towards a deadly […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy